Use of β-1,3 (4)-endoglucanohydrolase, β-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
View Patent ↗A method for the augmentation of immune function is described. The invention comprises a combination of β-1,3(4)-endoglucanohydrolase, β-1,3(4)glucan, diatomaceous earth, mineral clay and glucomannan, which is fed to or consumed by mammalian or avian species in amounts sufficient to augment immune function. The invention described may be admixed with feeds or foods, incorporated into pelleted feeds or foods or administered orally to mammalian and avian species.
1. A method for augmenting function of an animal's innate immune system, comprising:
providing a composition comprising a combination of β-glucans, β-1,3(4)-endoglucanohydrolase, diatomaceous earth, a mineral clay, and glucomannan; and
administering said composition to an animal selected from mammalian and avian species and known to have been exposed to a pathogen, thereby augmenting the animal's innate immune function and reducing susceptibility to an infection.
2. The method of claim 1 comprising administering the composition to an immunosuppressed mammalian or avian species.
3. The method of claim 2 wherein said animal is immunosuppressed as result of a cause selected from the group consisting of pregnancy, elevated stress hormone levels, drug treatment and pathogen exposure and combinations thereof.
4. The method of claim 2 , wherein the pathogen is a pathogenic mold.
5. The method of claim 4 , further comprising feeding the animal moldy feed, wherein the moldy feed is the source of the pathogen.
6. The method of claim 1 wherein said augmenting of the function of the animal's innate immune system includes increasing the expression of a molecule selected from the group consisting of L-selectin and interleukin-1β and combinations thereof.
7. The method of claim 1 wherein said mammalian species include all ruminant animals.
8. The method of claim 1 wherein said mammalian species include dairy cattle, beef cattle and sheep.
9. The method of claim 1 wherein said mammalian species include sheep.
10. The method of claim 1 wherein said avian species include poultry species used in commercial livestock production.
11. The method of claim 1 , wherein the mineral clay comprises montmorillonite, bentonite, aluminosilicate, or zeolite clays, or mixtures thereof.
12. The method of claim 1 , wherein the β-1,3(4)-endoglucanohydrolase is produced from submerged fermentation of Trichoderma ongibrachiatum.
13. The method of claim 1 , wherein the β-glucans and glucomannan are derived from boiling and enzyme autolysis of gram positive yeast cell walls from the genera of Saccharomyces.
14. The method of claim 13 , wherein the β-glucans and glucomannan are derived from boiling and enzyme autolysis of gram positive yeast cell walls from Saccharomyces cerevisiae.
15. The method of claim 1 , wherein said diatomaceous earth is calcined at a minimum temperature of 900° C.
16. The method of claim 1 , wherein said composition comprises between 15% and 40% diatomaceous earth, between 50% and 81% mineral clay, between 1.0% and 5.0% β-glucans, between 0.05% and 3.0% β-1,3(4)-endoglucanohydrolase and between 1% and 8.0% glucomannan.
17. The method of claim 1 , wherein said composition comprises between 20% and 30% diatomaceous earth, between 60% and 75% mineral clay, between 1.0% and 3.5% β-glucans, between 0.1% and 3.0% β-1,3(4)-endoglucanohydrolase and between 1.0% and 6.0% glucomannan.
18. The method of claim 1 , wherein said composition is admixed into foods or animal feedstuffs in a concentration of between 0.0125% and 5% by weight for the purpose of inhibiting fungal growth in feed, food or digesta.
19. The method of claim 1 , wherein said composition is admixed into a food or feedstuff and is subsequently fed to domestic livestock.
20. The method of claim 1 , wherein said composition is admixed into a food or feedstuff and is subsequently fed to ruminant livestock or avian livestock.
21. The method of claim 1 wherein said composition is a prophylactic when administered to said animal.
22. The method of claim 1 wherein said composition is administered to said animal contemporaneously with the exposure to the pathogen.
23. The method of claim 1 wherein said administering of said composition increases neutrophil function.
24. The method of claim 1 wherein said administering of said composition reduces pathogen load in the blood.
25. The method of claim 1 wherein said administering of said composition increases the expression levels of neutrophil L-selectin in said animal.
26. The method of claim 1 wherein said administering of said composition increases the expression levels of interleukin-1β in said animal.
27. The method of claim 1 wherein said administering of said composition increases neutrophil phagocytosis in said animal.
28. The method of claim 1 wherein said administering of said composition increases oxidative burst killing in said animal.
29. The method of claim 1 wherein said administering of said composition increases extrusion of neutrophil extracellular traps in said animal.
30. The method of claim 1 wherein the providing comprises formulating the composition.
31. The method of claim 1 wherein the composition consists essentially of β-glucans, β-1,3(4)-endoglucanohydrolase, diatomaceous earth, a mineral clay, and glucomannan.
32. The method of claim 1 , wherein the pathogen is a pathogenic mold.
33. The method of claim 1 , further comprising exposing the animal to the pathogen.